Schedule: Live Sessions


Preview the Sessions That Took Place Live at CHEST 2020

All live session recordings are now available for CHEST 2020 registrants through the “Live Sessions” section of CHEST 2020 lobby. 

Please note:
This agenda only shows the live CHEST 2020 sessions.
View the CHEST 2020 On Demand sessions.

After COVID: Complications of a New Infection and the Aftermath

This program will address the post-icu syndrome associated with COVID 19 infection. Recognized experts in the field of post-ICU syndrome will address the post-COVID syndrome and its unique features. The key issues will address the neurological complications of COVID including delirium and coma. Developing strategies for...

Antiviral therapies for COVID-19: Remdesivir and Beyond

Since the beginning of the COVID-19 pandemic, multiple antiviral agents have been advanced as potential therapies for COVID-19, including both novel agents and older drugs repurposed for use against SARS-CoV-2. To date, only the viral RNA polymerase inhibitor remdesivir has shown any clear clinical benefit. In this session, we will review the data behind remdesivir, as well as novel agents entering into human testing, such as EIDD-2801.

COVID-19 Vaccines and Prophylaxis

Modern vaccines come in a variety of forms, from live attenuated viruses such as the measles vaccine, to subunit vaccines such as vaccines for viral hepatitis. Each method carries potential risks and benefits in terms of protection and safety. The rapid spread of SARS-CoV-2 has led to a wide variety of new vaccine platforms entering into human trials at an unprecedented rate, such as replication-incompetent viral vectors and...

The CHEST 2020 schedule is subject to change.